NMN Synbiotics: A Multifaceted Therapeutic Approach for Alzheimer’s Disease

Caifeng Li,Xiaodong Zhao,Huilian Xu,Xiaoyong Liu,Yan He,Jinsong Gu
DOI: https://doi.org/10.1007/s11064-024-04210-z
IF: 4.4
2024-01-01
Neurochemical Research
Abstract:With the aging global population, Alzheimer’s disease (AD) has become a significant social and economic burden, necessitating the development of novel therapeutic strategies. This study investigates the therapeutic potential of nicotinamide mononucleotide (NMN) synbiotics, a combination of NMN, Lactiplantibacillus plantarum CGMCC 1.16089, and lactulose, in mitigating AD pathology. APP/PS1 mice were supplemented with NMN synbiotics and compared against control groups. The effects on amyloid-β (Aβ) deposition, intestinal histopathology, tight junction proteins, inflammatory cytokines, and reactive oxygen species (ROS) levels were assessed. NMN synbiotics intervention significantly reduced Aβ deposition in the cerebral cortex and hippocampus by 67
What problem does this paper attempt to address?